Ophthopedia Update:Tear Film Hyperosmolarity is Associated with Increased Variation of Light Scatter Following Cataract Surgery #Ophthomology #Eye #Ophthotwitter
Ophthopedia
Research Services
Boston, MA 1,135 followers
Latest updates about publications, scientific and clinical news from the field of Ophthalmology and Visual Sciences.
About us
Latest updates about publications, scientific and clinical news from the field of Ophthalmology and Visual Sciences.
- Website
-
https://twitter.com/ophthopedia
External link for Ophthopedia
- Industry
- Research Services
- Company size
- 2-10 employees
- Headquarters
- Boston, MA
- Type
- Nonprofit
- Founded
- 2018
- Specialties
- Ophthalmology, Eye, Eye Sugery, Medicine, Surgery, Healthcare, Optometry, Research, Trials, and Clinics
Locations
-
Primary
Boston, MA 02114, US
Employees at Ophthopedia
Updates
-
Ophthopedia Update:Response to “Telemedicine at a University Ophthalmology Practice During the Beginning of the COVID-19 Pandemic” [Letter] #Ophthomology #Eye #Ophthotwitter
Letter for the article Telemedicine at a University Ophthalmology Prac | OPTH
dovepress.com
-
Ophthopedia Update:Optic nerve head morphological variation in craniosynostosis: a cohort study: To evaluate optic nerve head morphology in children with craniosynostosis versus healthy controls. #Ophthalmology #Ophthotwitter #Scicomm
Optic nerve head morphological variation in craniosynostosis: a cohort study
ajo.com
-
Ophthopedia Update:Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration: The Port Delivery System with ranibizumab (PDS) is approved in the United States for neovascular age-related macular degeneration (nAMD). Portal (NCT03683251) is evaluating long-term safety and tolerability of the PDS in patients with nAMD who completed the phase II Ladder (NCT02510794) or phase III Archway (NCT03677934) trials. #Ophthalmology #Retina #Ophthotwitter
Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration
ophthalmologyretina.org
-
Ophthopedia Update:Artificial intelligence in corneal diseases: A narrative review: Corneal diseases represent a growing public health burden, especially in resource-limited settings lacking access to specialized eye care. Artificial intelligence (AI) offers promising solutions for automating the diagnosis and management of corneal conditions. This narrative review examines the application of AI in corneal diseases, focusing on keratoconus, infectious keratitis, pterygium, dry eye disease, Fuchs endothelial corneal dystrophy, and corneal transplantation. AI models integrating diverse imaging modalities (e.g., corneal topography, slit-lamp, and anterior segment OCT images) and clinical data have demonstrated high diagnostic accuracy, often outperforming human experts. #eye #Ophthalmology #CLAE
Artificial intelligence in corneal diseases: A narrative review
contactlensjournal.com
-
Ophthopedia Update:Non-redundant role of leishmanolysin-like (Lmln) zinc-metallopeptidase in retinal homeostasis: To determine if Lmln, a Zn-metallopeptidase, is important for retinal homeostasis. #Ophthalmology #Ophthotwitter #Scicomm
Non-redundant role of leishmanolysin-like (Lmln) zinc-metallopeptidase in retinal homeostasis
ajo.com
-
Ophthopedia Update:An Integrated 15-GEP/PRAME Tool May Improve Uveal Melanoma Prognostication: Good performance is seen with a new uveal melanoma prediction tool that combines 15-gene expression profile (15-GEP) data and screening for expression of a known metastasis-associated antigen (PRAME). #Ophthalmology #News
An Integrated 15-GEP/<em>PRAME</em> Tool May Improve Uveal Melanoma Prognostication
aao.org
-
Ophthopedia Update:Does the visual field improve after initiation of intraocular pressure lowering in the United Kingdom Glaucoma Treatment Study?: Evidence to support the hypothesis that visual field (VF) status can improve after initiation of intraocular pressure (IOP) reducing treatment is controversial. We take advantage of participant eligibility data from the United Kingdom Glaucoma Treatment Study (UKGTS) to test this hypothesis in newly diagnosed glaucomatous patients randomised to IOP lowering therapy or placebo. #Ophthalmology #Ophthotwitter #Scicomm
Does the visual field improve after initiation of intraocular pressure lowering in the United Kingdom Glaucoma Treatment Study?
ajo.com
-
ICYMI: Ophthopedia Update:Factors Affecting Quality of Life in Patients with Neovascular Age-Related Macular Degeneration: Short title: Factors affecting Quality of life in nAMD: Publication date: Available online 23 August 2024 Source: AJO International Author(s): Benjamin Sommer Thinggaard, Yousif Subhi, Fadumo Abdullah Ismail, Maria Pedersen, Lars Morsø, Jakob Grauslund, Lonny Stokholm #Ophthalmology #AJOInternational
Factors Affecting Quality of Life in Patients with Neovascular Age-Related Macular Degeneration: Short title: Factors affecting Quality of life in nAMD
-
Ophthopedia Update:Association of Gaps in Medical Insurance Coverage with Vision Care Benefits Among US Adults: .
Association of Gaps in Medical Insurance Coverage with Vision Care Benefits Among US Adults
tandfonline.com